Skip to search formSkip to main contentSkip to account menu

UNBS 5162

Known as: Naphthalimide Analogue UNBS5162, UNBS5162, UNBS-5162 
An amonafide (naphthalimide) derivative and pan-antagonist of chemokine ligand (CXCL) expression, with potential anti-angiogenic activity. Although… 
National Institutes of Health

Related topics

Related topics

4 relations
NCIt Antineoplastic Agent Terminologyanalogs & derivatives

Broader (2)

NaphthalimidesUrea

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
UNBS5162 Inhibits U251 Glioma Cells Proliferation and Metastasis byPromoting Apoptosis
2017
2017
UNBS 5162 inhibits the proliferation of esophageal cancer squamous cells via the PI 3 K / AKT signaling pathway
C-X-C motif chemokine ligand (CXCL) signaling has been demonstrated to be involved in cancer invasion and migration; therefore… 
2016
2016
Materials design for ambipolar devices: tuning orbital energetics in oligothiophene-naphthalimides semiconductors
Ambipolar organic field-effect transistors (OFETs), which can efficiently transport both holes and electrons,[1] using a single… 
2015
2015
Synthesis of novel naphthalimide tetrazoles and their antimicrobial evaluation in vitro
2007
2007
UNBS5162: a novel naphthalimide derivative with potent pro-autophagic effects in human cancer cells.
4831 UNBS5162 (N-{2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}urea) is a novel naphthalimide…